Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
about
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerMolecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tractr84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity inductionDoxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasisCharacterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouseNFATc1 regulates lymphatic endothelial developmentMicroenvironmental regulation of metastasisPhotoacoustic lymphatic imaging with high spatial-temporal resolution.Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.Genome-wide gene expression analysis implicates the immune response and lymphangiogenesis in the pathogenesis of fetal chylothoraxCoexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Tumour vascularization: sprouting angiogenesis and beyondRoles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.The VEGF family in cancer and antibody-based strategies for their inhibition.Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: a mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasisNeuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study.Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancerExpression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.Current concepts of metastasis in melanoma.Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma.Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermisLow molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathwaysRelationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.When it comes to blocking lymphatics, it is all a question of timeLymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma ModelsProtein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial Cells.Tumor lymphangiogenesis as a potential therapeutic target.A novel analysis strategy for integrating methylation and expression data reveals core pathways for thyroid cancer aetiology.Development of the endothelium: an emphasis on heterogeneityThe role of angiogenic factors in endometrial cancer.Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction.The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches.Metastasis: recent discoveries and novel treatment strategies.Targeting lymphangiogenesis to prevent tumour metastasisNew signals from the invasive front.
P2860
Q24651871-67C549AA-7BAB-4FA4-82F0-AB72D02154A0Q27013620-D6549300-942E-4085-AFA7-BE1B9FB8625DQ27321768-83DCCB66-AA2A-454E-8BD6-08EB5A372A71Q28469047-F222BA0E-AF9C-4721-BC37-3BEEEDE8DD08Q28588181-EB38D28B-AF28-4EBD-8993-CF0ECE4F46ABQ28593523-D1FF2556-9CE4-48F1-AB45-D0F9A570AFF6Q29547660-C68A48DA-FA52-42F0-8537-3E1B0F7D5D97Q30398562-7FD024E3-D6EC-4C34-B105-84FBBABD217CQ30580198-242B5633-AF9B-4C66-8EC7-681CDBD41730Q31057206-657C02B1-C226-4015-AF37-C0ACADC0284CQ33314445-04FDEBF2-538A-4E91-B69C-4EEADBE5F4D4Q33556162-DC6071D6-8B0A-4DF3-9F2C-17410DADF339Q33616384-42F713E9-B923-4AF4-87F2-9CE556D619BAQ33680436-A6AB874D-1465-4466-8444-EFDDCB31EDE5Q33712485-E8862CBD-9397-4AA4-B891-6F7F8C65EB14Q33733437-F92AFD7C-E9C4-44EE-8EC1-0F7641647257Q33761997-DD405FC9-A872-4359-9A08-AFAAA0E73885Q33789563-795A7A05-6DAB-4661-B00C-8D99787708EBQ33920927-C7ECEFA7-71F8-4BCE-896B-982A3A7D4B15Q34143330-85302D1D-22A3-4584-AD99-D799D9FC36ABQ34251088-A99C662B-272A-4410-96FF-9E2141DA3CB1Q34406774-F7F975F3-66A9-4CBD-9016-9F32FA122AA5Q34610427-4EDB27E6-A8B4-4034-AC85-3550EBB81D9EQ34990607-7B769BB0-D196-4A34-AD5B-247F957568E5Q35113731-DCA92EA4-8B37-4DFA-AA87-BBEF39447ADFQ35131321-CBD6470A-814E-4EF2-9696-A7FE763ADE46Q35171541-14EA27C0-9FA6-489F-832B-0691A4DA58B3Q35221926-EE565298-CA3E-4C35-92E3-07CE89FDCE2DQ35684375-ADDFCB7F-671A-4F6E-89C5-7EF07DBF3A86Q35758679-AD1AAEBE-824A-44BA-98A9-4C4A7E2CC185Q35838122-E90DC6B9-C532-4DC8-8BA0-B006ECA5C9F4Q35871560-78DBB9FF-17D3-4008-B8AC-6A0B1EF3E57FQ35893734-9F3E3328-A158-4D36-80C5-8B35067BECAFQ35903556-EBF98F63-6A12-4D75-9AE5-89AE67243D79Q36051470-EE706410-F421-4F87-A576-61FC013BDF65Q36339264-C1BC38A5-D09C-4015-BE17-560D00FE47BCQ36397316-6CC8BAE1-079E-48CC-BA99-AEFEF705142BQ36407511-EF277931-B4D2-4F72-B936-97B15B324232Q36461582-EF9BA23E-4926-468C-962C-BB3834265412Q36488744-56DB9FAF-0DB0-4999-87D3-762420A4DDF9
P2860
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@ast
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@en
type
label
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@ast
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@en
prefLabel
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@ast
Lymphatic vasculature: develop ...... r metastasis and inflammation.
@en
P50
P356
P1433
P1476
Lymphatic vasculature: develop ...... or metastasis and inflammation
@en
P2093
Marika J Karkkainen
P304
P356
10.1016/J.IT.2004.05.003
P577
2004-07-01T00:00:00Z